Retrobulbar 99mTc-Diethylenetriamine-Pentaacetic-Acid Uptake May Predict the Effectiveness of Immunosuppressive Therapy in Graves' Ophthalmopathy

Background: In Graves' ophthalmopathy (GO), only patients with immunologically active disease respond to immunosuppressive therapy. Previous studies and theoretical considerations suggest that elevated orbital 99m Tc-diethylenetriamine-pentaacetic-acid (DTPA) single photon emission computed tom...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Thyroid (New York, N.Y.) N.Y.), 2009-04, Vol.19 (4), p.375-380
Hauptverfasser:	Ujhelyi, Bernadett, Erdei, Annamaria, Galuska, Laszlo, Varga, Jozsef, Szabados, Lajos, Balazs, Erzsebet, Bodor, Miklos, Cseke, Bela, Karanyi, Zsolt, Leovey, Andras, Mezosi, Emese, Burman, Kenneth D., Berta, Andras, Nagy, Endre V.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Female Graves Ophthalmopathy - diagnostic imaging Graves Ophthalmopathy - drug therapy Humans Immunosuppressive Agents - therapeutic use Male Methylprednisolone - therapeutic use Middle Aged Orbit - diagnostic imaging Original Studies, Reviews, and Scholarly Dialog Predictive Value of Tests Radionuclide Imaging Radiopharmaceuticals Technetium Tc 99m Pentetate Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!